Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Businesswire05:15

Express News | Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Breakings05:15

Earnings Call Summary | Xeris Pharmaceuticals(XERS.US) Q3 2024 Earnings Conference

Futu NewsDec 30, 2024 19:54 · Conference Call

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

BusinesswireNov 26, 2024 20:00

When Will Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Become Profitable?

Simply Wall StNov 16, 2024 21:47

Craig-Hallum Maintains Xeris Pharmaceuticals(XERS.US) With Buy Rating, Announces Target Price $5

Futu NewsNov 11, 2024 22:31 · Ratings